UK markets closed

Nektar Therapeutics (ITH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.1340-0.0390 (-3.32%)
At close: 03:50PM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts12121212
Avg. Estimate-0.8-0.86-3.03-2.18
Low estimate-0.88-0.95-3.19-3.46
High estimate-0.73-0.68-2.780.09
Year ago EPS-0.61-0.65-2.49-3.03
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts12121212
Avg. Estimate27.87M28.72M108.57M275.04M
Low estimate23.83M23.48M100M85M
High estimate42.71M44.47M138.75M699.84M
Year ago sales30.03M23.46M152.91M108.57M
Sales growth (year/est)-7.20%22.40%-29.00%153.30%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.74-0.68-0.72-0.73
Actual EPS-0.61-0.65-0.68-0.69
Difference0.130.030.040.04
Surprise %17.60%4.40%5.60%5.50%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.8-0.86-3.03-2.18
7 days ago-0.8-0.86-3.03-2.19
30 days ago-0.8-0.86-3.03-2.19
60 days ago-0.79-0.84-3.05-2.27
90 days ago-0.79-0.84-3.05-2.27
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesITH.FIndustrySector(s)S&P 500
Current qtr.-31.10%N/AN/AN/A
Next qtr.-32.30%N/AN/AN/A
Current year-21.70%N/AN/AN/A
Next year28.10%N/AN/AN/A
Next 5 years (per annum)-7.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A